These include specific alleles of JAK2 that are associated with an increased risk of developing sporadic MPN [27], including one called 46/1 with a strong predisposition to the acquisition of either JAK2 V617F mutations [55] or TPO-R GOF mutations [56]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.